Company / Net Debt per Share
Arbutus Biopharma Corp Net Debt per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$0.09
FY2025
5-year range
-$1.22 / -$0.09
FY2021-FY2025
Trend
+55.7%
vs FY2024
Sector context
#53 of 82
Health Care
What the data says
At $-0.09, Arbutus Biopharma Corp's net debt per share ranks #30 of 82 in the Health Care sector. Increased from $-0.17 to $-0.09 over the past 2 years.
Based on SEC 10-K filings.
-0.09 in FY2025.
Increased from $-0.17 to $-0.09 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#30 of 82 in Health CareTop 35% of 82This company -$0.09 Sector average $13.70
▼
-100.7% below sector average
Key checks
Key Insights
- In FY2025, net debt per share increased 55.7% year-over-year.
- Ranks #53 out of 82 companies in the Health Care sector.
- Lowest net debt per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -11.01 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.09 | +55.7% |
| FY2024 | -$0.21 | -28.1% |
| FY2023 | -$0.17 | +21.4% |
| FY2022 | -$0.21 | +82.6% |
| FY2021 | -$1.22 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026